CLINICAL_TRIALS
trial_result
· 2018-07-20
Clinical Trial Update: Progesterone in Threatened Abortion [Phase 3]
Summary
A Phase 3 trial evaluating progesterone for threatened abortion in the first trimester has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IBSA Institut Biochimique SA | Conditions: Threatened Abortion in First Trimester | Phase 3 | Status: TERMINATED